Moderna claims vaccine 96% effective in teens 12 to 17

Moderna has claimed that its COVID-19 vaccine is effective up to 96% in teens aged 12 to 17, presenting a major boost to hopes of a full-time return to in-person learning in the fall.

The announcement is just one of several major developments Moderna revealed in its Q1 2021 Business Update.

Parents and students alike have complained about the issues faced by studying remotely, with some concerns that students were falling behind due to remote learning and may never catch up again.